EPIDEMIOLOGIYa PERELOMOV PROKSIMAL'NOGO OTDELA BEDRENNOY KOSTI


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Proximal femoral fractures are the most serious complications of osteoporosis. Their incidence varies in different countries. In the Russian Federation, epidemiology of this type of fractures was investigated in two multi-center studies. According to a recent study, in Russia high incidence of femoral fractures among men and modest among women was noted. Knowledge of the actual incidence of fractures should be the basis for the development of healthcare system for patients with proximal femoral fractures in our country.

Full Text

Restricted Access

References

  1. Gullberg B., Johnell J., Kanis J.A. World-wide projections for hip fracture. Osteoporos Int 1997; 7: 407-13.
  2. Lau E.M., Lee J.K., Suriwongpaisal P. et al. The incidence of hip fracture in four Asian countries; the Asian Osteoporosis Study (AOS). Osteoporos Int 2001; 12: 239-43.
  3. Bjorgul K., Reilkeras O. Incidence of hip fracture in a southeastern Norway: a study of 1,730 cervical and trochanteric fractures. Int Orthop 2007; 31(5): 665-69.
  4. Sernbo I., Gullberg B., Johnell O. Hip fracture in Malmo over three decades. Bone 1993; 14: S19-22.
  5. Kannus P., Niemi S., Parkkari J., et al. Hip fractures in Finland between 1970 and 1997 and predictions for the future. Lancet 1999; 353: 802-05.
  6. Wu T.Y., Jen M.H., Bottle A., et al. Admission rates and in-hospital mortality for hip fractures in England 1998 to 2009: time trends study. J Public Health (Oxf) 2011; 33(2): 284-91.
  7. Mann E., Icks A., Haastert B., Meyer G. Hip fracture incidence in the elderly in Austria: an epidemiological study covering the years 1994 to 2006. BMC Geriatr 2008; 8: 35.
  8. Chevalley T., Guilley E., Herrmann F.R., et al. Incidence of hip fractures over a 10-year period (1991-2000): reversal of a secular trend. Bone 2007; 40(5): 1284-89.
  9. Pentek M., Horvath C., Boncz I., et al. Epidemiology of osteoporosis related fractures in Hungary from the nationwide health insurance database, 1999-2003. Osteoporos Int 2008; 19: 243-49.
  10. Boereboom F.T.J., de Groot R.R.M., Raymakers J.A., Duursma S.A. The incidence of hip fractures in The Netherlands. Netherlands J Med 1991; 38(1-2): 51-58.
  11. Czerwinski E. The incidence and risk of hip fracture in Poland. Osteoporos Int 2009; 20: 1363-67.
  12. Лесняк О.М. Аудит состояния проблемы остеопороза в странах Восточной Европы и Центральной Азии 2010 / Prepared by the International Osteoporosis Foundation 2010. Naturaprint 2011. 66 с.
  13. Михайлов Е.Е., Беневоленская Л.И., Аникин С.Г. и др. Частота остеопоротических переломов основных локализаций среди городского населения России // Научно-практическая ревматология 2001. № 3. С. 75.
  14. Lesnyak О., Ershova O., Belova K., et al. Epidemiology of fracture in the Russian Federation and the development of a FRAX model. Arch Osteoporos doi: 10.1007/s11657-012-0082-3.
  15. Brauer C.A., Coca-Perraillon M., Cutler D.M., Rosen A.B. Incidence and mortality of hip fractures in the United States. JAMA 2009; 32(14): 1573-79.
  16. Leslie W.D., O'Donnell S., Lagace C., et al. Population-based Canadian hip fracture rates with international comparisons. Osteoporos Int 2009; 21(8): 1-6.
  17. Clark P., Lavielle P., Franco-Marina F., et al. Incidence rates and life-time risk of hip fractures in Mexicans over 50 years of age: a population-based study. Osteoporos Int 2005; 16: 2025-30.
  18. Morosano M., Masoni A., Sanchez A. Incidence of hip fractures in the city of Rosario, Argentina. Osteoporos Int 2005; 16: 1339-44.
  19. Riera-Espinoza G. Epidemiology of osteoporosis in Latin America 2008. Salud Publica Mex 2009; 51: 52-5.
  20. Hagino H., Katagiri H., Okano T., et al. Increasing incidence of hip fracture in Tottori Prefecture, Japan: Trend from 1986 to 2001. Osteoporos Int 2005; 16: 1963-68.
  21. Koh L.K., Saw S.M., Lee J.J., et al.; National Working Committee on Osteoporosis. Hip fracture incidence rates in Singapore 1991-1998. Osteoporos Int 2001; 12: 311-18.
  22. Lim S., Koo B.K., Lee E.J., et al. Incidence of hip fractures in Korea. J Bone Miner Metab 2008; 26: 400-05.
  23. Lau E.M., Cooper C., Fung H., et al. Hip fracture in Hong Kong over the last decade - a comparison with the UK. J Public Health Med 1999; 21: 249-50.
  24. Shao C.J., Hsieh Y.H., Tsai C.H., Lai K.A. A nationwide seven-year trend of hip fractures in the elderly population of Taiwan. Bone 2009 Jan; 44(1): 125-29.
  25. Moayyeri A., Soltani A., Larijani B., et al. Epidemiology of hip fracture in Iran: Results from the Iranian multicenter study on accidental injuries. Osteoporos Int 2006; 17: 1252-57.
  26. Zebaze R.M., Seeman E. Epidemiology of hip and wrist fractures in Cameroon, Africa. Osteoporos Int 2003; 14: 301-05.
  27. Boufous S., Finch C.F., Lord S.R. Incidence of hip fracture in New South Wales: are our efforts having an effect? Medical J Australia 2004; 21; 180(12): 623-26.
  28. Турекулова А.А. Распространенность остеопоротических переломов в городской популяции // Вісник морфологіі. Reports of Morphology 2008. 14. № 1. С. 134-38.
  29. Kanis J.A., Oden A., Mc Closkey E.V., et al. A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int doi: 10.1007/s00198-012-1964-63.
  30. Остеопороз: Диагностика, профилактика и лечение. Клинические рекомендации / Под ред. О.М. Лесняк, Л.И. Беневоленской. 2-е изд. М., 2008. 272 с.
  31. Institute for Clinical Systems Improvement (ICSI) Health Care Guideline: Diagnosis and Treatment of Osteoporosis, 3rd ed. 2004.
  32. American association of endocrinologists (AACE) medical guidelines for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocrine Practice 2003; 9(6): 544-64.
  33. Brown J.P., Josse R.G. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 2002; 167(10): S1-S34.
  34. Kanis J.A., Burlet N., Cooper C., et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2008; 19: 399-428.
  35. Shiraishi A., Takeda S., Masaki T., et al. Alfacalcidol inhibits bone resorption and stimulates formation in an ovariectomized rat model of osteoporosis: distinct action from estrogen. J Bone Miner Res 2000; 15: 770-79.
  36. Seino Y., Ishizuka S., Shima M., Tanaka H. Vitamin D in bone formation. Osteoporos Int 1993; 3: 196-98.
  37. van Driel M., Pols H.A., van Leeuwen J.P. Osteoblast differentiation and control by vitamin D and vitamin D metabolites. Curr Pharm Des 2004; 10: 2535-55.
  38. Schacht E. Rationale for treatment of involutional osteoporosis in women and for prevention and treatment of corticosteroid-induced osteoporosis with alfacalcidol. Calcif Tissue Int 1999; 65: 317-27.
  39. Yamato H., Okazaki R., Ishii T., et al. Effect of 24R, 25-dihydroxyvitamin D3 on the formation and function of osteoclastic cells. Calcif Tissue Int 1993; 52: 255-60.
  40. Boland R. Role of vitamin D in skeletal muscle function. Endocr Rev 1986; 784: 434-48.
  41. Bischoff H.A., Borchers M., Gudat F., et al. In situ detection of 1,25-dihydroxyvitamin D receptor in human skeletal muscle tissue. Histochem 2001; 33: 19-24.
  42. Bischoff H.A., Stahelin H.B., Urscheler N., et al. Muscle strength in the elderly: its relation to vitamin D metabolites. Arch Phys Med Rehabil 1999; 80: 54-58.
  43. Dukas L., Schacht E., Bischoff H.A. Better functional mobility in community-dwelling elderly is related to D-hormone serum levels and to a daily calcium intake. J Nutr Health Aging 2005; 9(5): 347-51.
  44. Bischoff-Ferrari H.A., Giovannucci E., Willett W.C., et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006; 84: 18-28.
  45. Chapuy M.C., Arlot M.E., Delmas P.D., Meunier P.J. Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women.BMJ 1994; 308: 1081-82.
  46. Nurmi-Luthje I., Luthje P., Kaukonen J.P., et al. Post-fracture prescribed calcium and vitamin D supplements alone or, in females, with concomitant anti-osteoporotic drugs is associated with lower mortality in elderly hip fracture patients: a prospective analysis. Drugs Aging 2009; 26(5): 409-21.
  47. Nurmi-Luthje I., Luthje P., Kaukonen J.P., et al. Post-fracture prescribed calcium and vitamin D supplements alone or, in females, with concomitant anti-osteoporotic drugs is associated with lower mortality in elderly hip fracture patients: a prospective analysis. Drugs Aging 2009; 26(5): 409-21

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2012 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies